Prevalence of hearing loss in patients with sickle cell disease in the southeast of Iran

G. Miri-Aliabad, Majid Naderi, Aziz Eghbali, E. Pirasteh, Farzad Hamzehpour, Asma Erish
{"title":"Prevalence of hearing loss in patients with sickle cell disease in the southeast of Iran","authors":"G. Miri-Aliabad, Majid Naderi, Aziz Eghbali, E. Pirasteh, Farzad Hamzehpour, Asma Erish","doi":"10.18502/ijpho.v14i2.15274","DOIUrl":null,"url":null,"abstract":"Background: One of the complications of sickle cell disease (SCD) is hearing loss. The purpose of the present study is to determine the prevalence of hearing loss in SCD. \nMaterials and Methods: This is a descriptive-analytical cross-sectional study conducted on 100 patients with SCD in 2019-2020. All the patients underwent otololaryngological examination and audiometric tests to assess their hearing status. The type and severity of hearing loss were determined, the demographic information of the patients was recorded, and the data were analyzed using the SPSS software version 21, a Chi-square test, and the Kruskal-Wallis test. The P-values of < 0.05 were considered statistically significant. \nResults: The mean age of the patients was 17.6 ± 10.8 years. Of them, 60% were male. Hearing loss was diagnosed in 26 patients (26%), 16 of whom had sensorineural hearing loss (SNHL) and 10 had conductive hearing loss (CHL). In terms of the disease severity, 12, 10, 3 and 1 patients had mild, moderate, severe and profound hearing loss, respectively. The mean age of the patients with SNHL was significantly higher than the median age of the subjects with CHL (p-value = 0.043). Also, the patients with hearing loss had no statistically significant difference in terms of the variables of age, gender, unilateral or bilateral ear involvement and type of SCD (p-value = 0.069). \nConclusion: This study revealed a hearing loss frequency of 26% among patients with SCD. Regular hearing assessment and timely treatment and rehabilitation measures are recommended for these patients.","PeriodicalId":129489,"journal":{"name":"Iranian Journal of Pediatric Hematology &amp; Oncology","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pediatric Hematology &amp; Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijpho.v14i2.15274","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: One of the complications of sickle cell disease (SCD) is hearing loss. The purpose of the present study is to determine the prevalence of hearing loss in SCD. Materials and Methods: This is a descriptive-analytical cross-sectional study conducted on 100 patients with SCD in 2019-2020. All the patients underwent otololaryngological examination and audiometric tests to assess their hearing status. The type and severity of hearing loss were determined, the demographic information of the patients was recorded, and the data were analyzed using the SPSS software version 21, a Chi-square test, and the Kruskal-Wallis test. The P-values of < 0.05 were considered statistically significant. Results: The mean age of the patients was 17.6 ± 10.8 years. Of them, 60% were male. Hearing loss was diagnosed in 26 patients (26%), 16 of whom had sensorineural hearing loss (SNHL) and 10 had conductive hearing loss (CHL). In terms of the disease severity, 12, 10, 3 and 1 patients had mild, moderate, severe and profound hearing loss, respectively. The mean age of the patients with SNHL was significantly higher than the median age of the subjects with CHL (p-value = 0.043). Also, the patients with hearing loss had no statistically significant difference in terms of the variables of age, gender, unilateral or bilateral ear involvement and type of SCD (p-value = 0.069). Conclusion: This study revealed a hearing loss frequency of 26% among patients with SCD. Regular hearing assessment and timely treatment and rehabilitation measures are recommended for these patients.
伊朗东南部镰状细胞病患者听力损失的患病率
背景:听力损失是镰状细胞病(SCD)的并发症之一。本研究旨在确定 SCD 中听力损失的患病率。材料和方法:这是一项描述性分析横断面研究,对象是 2019-2020 年的 100 名 SCD 患者。所有患者均接受了耳鼻喉科检查和听力测试,以评估其听力状况。研究人员确定了听力损失的类型和严重程度,记录了患者的人口统计学信息,并使用SPSS软件21版、Chi-square检验和Kruskal-Wallis检验对数据进行分析。P值小于0.05为差异有统计学意义。结果患者的平均年龄为(17.6 ± 10.8)岁。其中 60% 为男性。26名患者(26%)被诊断出患有听力损失,其中16人患有感音神经性听力损失(SNHL),10人患有传导性听力损失(CHL)。就疾病严重程度而言,轻度、中度、重度和极重度听力损失患者分别为 12 人、10 人、3 人和 1 人。SNHL患者的平均年龄明显高于CHL患者的中位年龄(P值=0.043)。此外,听力损失患者在年龄、性别、单侧或双侧耳朵受累以及 SCD 类型等变量方面也没有统计学意义上的差异(p 值 = 0.069)。结论本研究显示,SCD 患者中听力损失的频率为 26%。建议对这些患者定期进行听力评估,并及时采取治疗和康复措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信